Potassium Phosphates Injection
Product Images NDC 69097-055

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Potassium Phosphates (NDC 69097-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-15ml (Carton 15ml)

Packaging label for Potassium Phosphates Injection, USP, 236 mg/mL strength. The label includes the product name, dosage form as intravenous injection, and strength information prominently displayed on a green background. The labeler is Cipla USA Inc. Additional text includes ingredient details, barcodes, and regulatory information arranged across the foldout label layout.*

FDA Label Image

Carton-50ml (Carton 50ml)

Packaging label for Potassium Phosphates injection by Cipla USA Inc. The label includes the drug name, strength information (236 mg/mL and 224 mg/mL), and usage instructions, designed for intravenous administration. The layout shows all sides of the folded carton with branding, drug identification, and regulatory information.*

FDA Label Image

Carton-5ml (Carton 5ml)

Packaging label for Potassium Phosphates Injection, USP, an intravenous injection. The label shows strengths of Potassium 236 mg/mL and Phosphates 224 mg/mL. It includes dosage information, manufacturer Cipla USA Inc., and various regulatory details. The design features black, white, orange, and blue text on a white background.*

FDA Label Image

Vial-15ml (Vial 15ml)

Potassium Phosphates Injection, USP label for intravenous use, containing 15 mL single-dose vial. The vial includes 45 mmol/15 mL phosphate and 66 mEq/15 mL potassium with preservative-free solution. Label states caution for intravenous use only, storage conditions, and manufacturer information: Cipla Ltd., India, and Cipla USA Inc., Warren, NJ.*

FDA Label Image

Vial-50ml (Vial 50ml)

Potassium Phosphates Injection label for 150 mmol/50 mL and 220 mEq/50 mL strengths, preservative free sterile intravenous solution in a 50 mL vial. The label includes dosing information, storage instructions, and manufacturer details for Cipla USA Inc., Warren, NJ. The packaging cautions to discard unused portions and states the product is for intravenous use only.*

FDA Label Image

Vial-5ml (Vial 5ml)

Potassium Phosphates Injection, USP label for intravenous use by Cipla USA Inc. It is a 5 mL single-dose vial containing 236 mg/mL potassium phosphates with phosphate concentrations of 15 mmol/5 mL and potassium 22 mEq/5 mL. The label notes the solution is preservative-free, sterile, nonpyrogenic, and must be diluted prior to use. Storage instructions and lot/expiration date fields are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.